285 related articles for article (PubMed ID: 22194329)
1. Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations.
Xu Y; Li MJ; Greenblatt H; Chen W; Paz A; Dym O; Peleg Y; Chen T; Shen X; He J; Jiang H; Silman I; Sussman JL
Acta Crystallogr D Biol Crystallogr; 2012 Jan; 68(Pt 1):13-25. PubMed ID: 22194329
[TBL] [Abstract][Full Text] [Related]
2. Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study.
Chakraborty S; Kumar S; Basu S
Neurochem Int; 2011 Jul; 58(8):914-23. PubMed ID: 21354237
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into the inhibitory mechanism of bi-functional bis-tryptoline triazole against β-secretase (BACE1) enzyme.
Narang SS; Goyal D; Goyal B
Amino Acids; 2019 Nov; 51(10-12):1593-1607. PubMed ID: 31654211
[TBL] [Abstract][Full Text] [Related]
4. Acylguanidines as small-molecule beta-secretase inhibitors.
Cole DC; Manas ES; Stock JR; Condon JS; Jennings LD; Aulabaugh A; Chopra R; Cowling R; Ellingboe JW; Fan KY; Harrison BL; Hu Y; Jacobsen S; Jin G; Lin L; Lovering FE; Malamas MS; Stahl ML; Strand J; Sukhdeo MN; Svenson K; Turner MJ; Wagner E; Wu J; Zhou P; Bard J
J Med Chem; 2006 Oct; 49(21):6158-61. PubMed ID: 17034121
[TBL] [Abstract][Full Text] [Related]
5. A comparative molecular dynamics study on BACE1 and BACE2 flap flexibility.
Kumalo HM; Soliman ME
J Recept Signal Transduct Res; 2016 Oct; 36(5):505-14. PubMed ID: 26804314
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking based virtual screening of natural compounds as potential BACE1 inhibitors: 3D QSAR pharmacophore mapping and molecular dynamics analysis.
Kumar A; Roy S; Tripathi S; Sharma A
J Biomol Struct Dyn; 2016; 34(2):239-49. PubMed ID: 25707809
[TBL] [Abstract][Full Text] [Related]
7. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions.
Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH
Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541
[TBL] [Abstract][Full Text] [Related]
8. Why does beta-secretase zymogen possess catalytic activity? Molecular modeling and molecular dynamics simulation studies.
Zuo Z; Gang C; Zou H; Mok PC; Zhu W; Chen K; Jiang H
Comput Biol Chem; 2007 Jun; 31(3):186-95. PubMed ID: 17500040
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycan-induced activation of the beta-secretase (BACE1) of Alzheimer's disease.
Klaver DW; Wilce MC; Gasperini R; Freeman C; Juliano JP; Parish C; Foa L; Aguilar MI; Small DH
J Neurochem; 2010 Mar; 112(6):1552-61. PubMed ID: 20067575
[TBL] [Abstract][Full Text] [Related]
10. A PM7 dynamic residue-ligand interactions energy landscape of the BACE1 inhibitory pathway by hydroxyethylamine compounds. Part I: The flap closure process.
Gueto-Tettay C; Martinez-Consuegra A; Zuchniarz J; Gueto-Tettay LR; Drosos-Ramírez JC
J Mol Graph Model; 2017 Sep; 76():274-288. PubMed ID: 28746905
[TBL] [Abstract][Full Text] [Related]
11. A molecular dynamics study of the BACE1 conformational change from Apo to closed form induced by hydroxyethylamine derived compounds.
Gueto-Tettay C; Zuchniarz J; Fortich-Seca Y; Gueto-Tettay LR; Drosos-Ramirez JC
J Mol Graph Model; 2016 Nov; 70():181-195. PubMed ID: 27750187
[TBL] [Abstract][Full Text] [Related]
12. Computational modeling of substrate specificity and catalysis of the β-secretase (BACE1) enzyme.
Barman A; Schürer S; Prabhakar R
Biochemistry; 2011 May; 50(20):4337-49. PubMed ID: 21500768
[TBL] [Abstract][Full Text] [Related]
13. Characterization of autocatalytic conversion of precursor BACE1 by heteronuclear NMR spectroscopy.
Wang YS; Beyer BM; Senior MM; Wyss DF
Biochemistry; 2005 Dec; 44(50):16594-601. PubMed ID: 16342950
[TBL] [Abstract][Full Text] [Related]
14. Structural insight into the mechanism of amyloid precursor protein recognition by β-secretase 1: A molecular dynamics study.
Chakraborty S; Basu S
Biophys Chem; 2015 Jul; 202():1-12. PubMed ID: 25863345
[TBL] [Abstract][Full Text] [Related]
15. Conformational flexibility of beta-secretase: molecular dynamics simulation and essential dynamics analysis.
Xiong B; Huang XQ; Shen LL; Shen JH; Luo XM; Shen X; Jiang HL; Chen KX
Acta Pharmacol Sin; 2004 Jun; 25(6):705-13. PubMed ID: 15169620
[TBL] [Abstract][Full Text] [Related]
16. Functional plasticity in the substrate binding site of beta-secretase.
Gorfe AA; Caflisch A
Structure; 2005 Oct; 13(10):1487-98. PubMed ID: 16216580
[TBL] [Abstract][Full Text] [Related]
17. A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo.
Atwal JK; Chen Y; Chiu C; Mortensen DL; Meilandt WJ; Liu Y; Heise CE; Hoyte K; Luk W; Lu Y; Peng K; Wu P; Rouge L; Zhang Y; Lazarus RA; Scearce-Levie K; Wang W; Wu Y; Tessier-Lavigne M; Watts RJ
Sci Transl Med; 2011 May; 3(84):84ra43. PubMed ID: 21613622
[TBL] [Abstract][Full Text] [Related]
18. Modulation of in vitro activity of zymogenic and mature recombinant human β-secretase by dietary plants.
Sheean P; Rout MK; Head RJ; Bennett LE
FEBS J; 2012 Apr; 279(7):1291-305. PubMed ID: 22325686
[TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
[TBL] [Abstract][Full Text] [Related]
20. Determination of the protonation state for the catalytic dyad in β-secretase when bound to hydroxyethylamine transition state analogue inhibitors: A molecular dynamics simulation study.
Gueto-Tettay C; Pestana-Nobles R; Drosos-Ramirez JC
J Mol Graph Model; 2016 May; 66():155-67. PubMed ID: 27111489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
